The results obtained by our group in a further clinical trial agreed with Oades et al. [42], as no significant differences in serum S100B levels between ADHD children and controls were found; nevertheless, we also revealed that patients with depressive symptoms were prone to show higher S100B levels [45]. Here, S100B is linked to attention deficit-hyperactivity disorder.